Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenetics of acenocoumarol pharmacodynamics.
Morin S, Bodin L, Loriot MA, Thijssen HH, Robert A, Strabach S, Verstuyft C, Tregouet DA, Dubert L, Laurent-Puig P, Funck-Brentano C, Jaillon P, Beaune PH, Becquemont L. Morin S, et al. Among authors: jaillon p. Clin Pharmacol Ther. 2004 May;75(5):403-14. doi: 10.1016/j.clpt.2004.01.008. Clin Pharmacol Ther. 2004. PMID: 15116053
Is diclofenac a valuable CYP2C9 probe in humans?
Morin S, Loriot MA, Poirier JM, Tenneze L, Beaune PH, Funck-Brentano C, Jaillon P, Becquemont L. Morin S, et al. Among authors: jaillon p. Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):793-7. doi: 10.1007/s002280000240. Eur J Clin Pharmacol. 2001. PMID: 11294368 Clinical Trial.
Genetic and environmental risk factors for oral anticoagulant overdose.
Verstuyft C, Robert A, Morin S, Loriot MA, Flahault A, Beaune P, Funck-Brentano C, Jaillon P, Becquemont L. Verstuyft C, et al. Among authors: jaillon p. Eur J Clin Pharmacol. 2003 Mar;58(11):739-45. doi: 10.1007/s00228-002-0538-2. Epub 2003 Feb 18. Eur J Clin Pharmacol. 2003. PMID: 12634980
[A new, rapid and robust genotyping method for CYP2C9 and MDR1].
Verstuyft C, Morin S, Yang J, Loriot MA, Barbu V, Kerb R, Brinkmann U, Beaune P, Jaillon P, Becquemont L. Verstuyft C, et al. Among authors: jaillon p. Ann Biol Clin (Paris). 2003 May-Jun;61(3):305-9. Ann Biol Clin (Paris). 2003. PMID: 12805007 Free article. French.
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.
Verstuyft C, Delavenne X, Rousseau A, Robert A, Tod M, Diquet B, Lebot M, Jaillon P, Becquemont L. Verstuyft C, et al. Among authors: jaillon p. Clin Pharmacokinet. 2012 Jan 1;51(1):41-53. doi: 10.2165/11595560-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22149257 Free article. Clinical Trial.
235 results